Jun Zhang, M.D.
Houston Methodist Cancer Center · Huashan Hospital · Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jun Zhang, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:17 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03236935 · Phase Ib of L-NMMA and PembrolizumabThe Methodist Hospital Research Institute · completed · Non-Small Cell Lung Cancer, Malignant Melanoma, Head and Neck Squamous Cell Carcinoma · principal investigator
- Ph2NCT02855788 · Metronomic Chemotherapy in Advanced Gastric CancerHuashan Hospital · unknown · Metastatic Gastric Cancer, Locally Advanced Gastric Cancer · study director
- Ph1NCT02018523 · Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung CancerJun Zhang · terminated · Carcinoma, Non-Small-Cell Lung · principal investigator
- Ph3NCT01014845 · Clinical Trial of Recombinant Hepatitis E VaccineXiamen University · completed · Hepatitis E · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.